Preclinical development of sodium fusidate antibiotic cutaneous spray based on water-free lipid formulation system

Jan Holmbäck1, Vibhu Rinwa1, Jenny Johansson2

  • 1Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg 16C, Stockholm SE-106 91, Sweden; Lipidor AB, Svärdvägen 13, Danderyd SE-182 33, Sweden.

Insights

New sprayable formulations of sodium fusidate demonstrate enhanced skin penetration and potent antibacterial activity, potentially reducing treatment times and combating antibiotic resistance in skin infections.

Area of Science:

  • Dermatology
  • Microbiology
  • Pharmaceutical Sciences

Background:

  • Topical antibiotics are crucial for treating skin infections, but resistance to agents like fusidic acid is a growing concern due to lengthy treatment durations.
  • Developing more effective topical formulations could shorten treatment periods, mitigate bacterial resistance, and improve patient outcomes.

Purpose of the Study:

  • To evaluate novel water-free, lipid-based sprayable formulations (AKVANO®) containing sodium fusidate for enhanced drug delivery.
  • To assess the in vitro skin permeability and ex vivo/in vivo antibacterial efficacy of these new formulations compared to a commercial cream.

Main Methods:

  • Formulations with varying sodium fusidate concentrations were tested for in vitro skin permeation using artificial skin membranes.
  • Antibacterial properties were assessed using ex vivo and in vivo skin wound infection models.
  • Comparison was made against a commercially available fusidic acid cream (Fucidin®).

Main Results:

  • The novel sodium fusidate formulations exhibited significantly higher skin permeation (up to 60%) compared to Fucidin® cream (3%).
  • These formulations demonstrated superior antibacterial effects, with a clear dose-response relationship observed for sodium fusidate.
  • Spray application facilitated even skin coverage and non-touch application.

Conclusions:

  • The developed sprayable formulations offer superior skin permeation and antibacterial efficacy for sodium fusidate.
  • This technology has the potential to shorten treatment durations for skin infections, thereby reducing the risk of bacterial resistance.
  • Spray administration ensures efficient, non-contact drug delivery.